1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Cancer Hormone Therapy Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Cancer Hormone Therapy Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Cancer Hormone Therapy Market Regional Analysis
6.2 Europe Cancer Hormone Therapy Market Revenue 2021-2031 (US$ Million)
6.3 Europe Cancer Hormone Therapy Market Forecast Analysis
7. Europe Cancer Hormone Therapy Market Analysis – by Drug Class
7.1 GnRH Analogs
- 7.1.1 Overview
- 7.1.2 GnRH Analogs: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 GnRH Antagonists
- 7.2.1 Overview
- 7.2.2 GnRH Antagonists: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Androgen Receptor Antagonists
- 7.3.1 Overview
- 7.3.2 Androgen Receptor Antagonists: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Aromatase Inhibitors
- 7.4.1 Overview
- 7.4.2 Aromatase Inhibitors: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Selective Estrogen Receptor Modulators
- 7.5.1 Overview
- 7.5.2 Selective Estrogen Receptor Modulators: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Estrogen Receptor Antagonists
- 7.6.1 Overview
- 7.6.2 Estrogen Receptor Antagonists: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.7 Thyroid Hormone Therapy
- 7.7.1 Overview
- 7.7.2 Thyroid Hormone Therapy: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.8 Other Drug Classes
- 7.8.1 Overview
- 7.8.2 Other Drug Classes: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Europe Cancer Hormone Therapy Market Analysis – by Cancer Type
8.1 Breast Cancer
- 8.1.1 Overview
- 8.1.2 Breast Cancer: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Prostate Cancer
- 8.2.1 Overview
- 8.2.2 Prostate Cancer: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Endometrial Cancer
- 8.3.1 Overview
- 8.3.2 Endometrial Cancer: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Ovarian Cancer
- 8.4.1 Overview
- 8.4.2 Ovarian Cancer: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Thyroid Cancer
- 8.5.1 Overview
- 8.5.2 Thyroid Cancer: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Other Cancer Types
- 8.6.1 Overview
- 8.6.2 Other Cancer Types: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Europe Cancer Hormone Therapy Market Analysis – by Route of Administration
9.1 Oral
- 9.1.1 Overview
- 9.1.2 Oral: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Injectable
- 9.2.1 Overview
- 9.2.2 Injectable: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Implantable
- 9.3.1 Overview
- 9.3.2 Implantable: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. Europe Cancer Hormone Therapy Market Analysis – by Sales Channel
10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Hospitals: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.2 Cancer Treatment Centers
- 10.2.1 Overview
- 10.2.2 Cancer Treatment Centers: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.3 Specialty Clinics
- 10.3.1 Overview
- 10.3.2 Specialty Clinics: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.4 Retail Pharmacies
- 10.4.1 Overview
- 10.4.2 Retail Pharmacies: Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
11. Europe Cancer Hormone Therapy Market – Europe Analysis
11.1 Overview
11.2 Europe
- 11.2.1 Europe Cancer Hormone Therapy Market Breakdown, by Key
Country, 2025 and 2031 (%)
- 11.2.1.1 Europe Cancer Hormone Therapy Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 Germany:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.1.1 Germany: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.1.2 Germany: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.1.3 Germany: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.1.4 Germany: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.2 Italy:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.2.1 Italy: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.2.2 Italy: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.2.3 Italy: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.2.4 Italy: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.3 France:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.3.1 France: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.3.2 France: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.3.3 France: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.3.4 France: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.4 U.K.:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.4.1 U.K.: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.4.2 U.K.: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.4.3 U.K.: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.4.4 U.K.: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.5 Spain:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.5.1 Spain: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.5.2 Spain: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.5.3 Spain: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.5.4 Spain: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.6 Belgium:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.6.1 Belgium: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.6.2 Belgium: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.6.3 Belgium: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.6.4 Belgium: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.7 Netherlands:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.7.1 Netherlands: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.7.2 Netherlands: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.7.3 Netherlands: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.7.4 Netherlands: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.8 Luxembourg:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.8.1 Luxembourg: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.8.2 Luxembourg: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.8.3 Luxembourg: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.8.4 Luxembourg: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.9 Norway:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.9.1 Norway: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.9.2 Norway: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.9.3 Norway: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.9.4 Norway: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.10 Finland:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.10.1 Finland: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.10.2 Finland: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.10.3 Finland: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.10.4 Finland: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.11 Denmark:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.11.1 Denmark: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.11.2 Denmark: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.11.3 Denmark: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.11.4 Denmark: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.12 Sweden:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.12.1 Sweden: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.12.2 Sweden: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.12.3 Sweden: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.12.4 Sweden: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.13 Switzerland:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.13.1 Switzerland: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.13.2 Switzerland: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.13.3 Switzerland: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.13.4 Switzerland: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.14 Austria:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.14.1 Austria: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.14.2 Austria: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.14.3 Austria: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.14.4 Austria: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.15 Greece:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.15.1 Greece: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.15.2 Greece: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.15.3 Greece: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.15.4 Greece: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.16 Portugal:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.16.1 Portugal: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.16.2 Portugal: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.16.3 Portugal: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.16.4 Portugal: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.17 Russia:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.17.1 Russia: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.17.2 Russia: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.17.3 Russia: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.17.4 Russia: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.18 Poland:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.18.1 Poland: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.18.2 Poland: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.18.3 Poland: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.18.4 Poland: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.19 Romania:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.19.1 Romania: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.19.2 Romania: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.19.3 Romania: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.19.4 Romania: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.20 Czech Republic:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.20.1 Czech Republic: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.20.2 Czech Republic: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.20.3 Czech Republic: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.20.4 Czech Republic: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.21 Ukraine:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.21.1 Ukraine: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.21.2 Ukraine: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.21.3 Ukraine: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.21.4 Ukraine: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.22 Slovakia:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.22.1 Slovakia: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.22.2 Slovakia: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.22.3 Slovakia: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.22.4 Slovakia: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
- 11.2.1.23 Bulgaria:
Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.23.1 Bulgaria: Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
- 11.2.1.23.2 Bulgaria: Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
- 11.2.1.23.3 Bulgaria: Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
- 11.2.1.23.4 Bulgaria: Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Pfizer Inc
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 AbbVie
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Johnson & Johnson
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Novartis AG
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 AstraZeneca
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Sanofi
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Eli Lilly and Co
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 F. Hoffmann-La Roche Ltd
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Astellas Pharma Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Ipsen Pharma
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Get Free Sample For Europe Cancer Hormone Therapy Market
